Professor Lars Lannfelt, awarded the CTAD Lifetime Achievement Award in recognition for his pioneering work in Alzheimer's Disease

Contributed by: PR Newswire

Tags

BIOARCTIC-award

More Like This

Lifetime Achievement Award, lecanemab and biomarkers in focus at CTAD

BioArctic: Professor Lars Lannfelt, awarded Fondation Recherche Alzheimer's European Grand Prix for his contributions to science and treatment of Alzheimer's disease

Lars Lannfelt, Pär Gellerfors, and Gunilla Osswald awarded Uppsala University's Innovation and Entrepreneurship Prize

BioArctic: Latest data on lecanemab to be presented at the 2024 AD/PD™ congress

BioArctic: New data on lecanemab presented at the 2024 AD/PD™ congress

Lecanemab data presented at CTAD on early initiation and long-term treatment suggest increased patient benefit with maintained safety profile

Long-term treatment data for lecanemab to be presented at AAIC 2024

Lecanemab winner in two categories at The Scrip Awards 2023